Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Linagliptin”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT02191228
What this trial is testing

Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Single and Multiple Doses of Linagliptin Tablets in Patients With Different Degrees of Renal Impairment in Comparison to Subjects With Normal Renal Function

Who this might be right for
Renal Insufficiency
Boehringer Ingelheim 51
Early research (Phase 1)Study completedNCT07213895
What this trial is testing

Bioequivalence Study to Compare Empagliflozin/Linagliptin/Metformin HCL 25mg/5mg/1000mg Extended-Release Tablets Versus Trijardy® XR Extended Release Film Coated Tablets

Who this might be right for
Type 2 Diabetes Mellitus (T2DM)
Humanis Saglık Anonim Sirketi 14
Early research (Phase 1)Study completedNCT05874167
What this trial is testing

A Pharmacokinetic Study of DW6013 (FDC of Linagliptin and Metformin) in Healthy Adult Volunteers

Who this might be right for
Healthy Subjects
Dong Wha Pharmaceutical Co. Ltd. 50
Large-scale testing (Phase 3)UnknownNCT03051243
What this trial is testing

Safety and Efficiency of Linagliptin (Trajenta) in the Setting of Internal Medicine Department

Who this might be right for
DM2
Rabin Medical Center 60
Not applicableStudy completedNCT02197078
What this trial is testing

Active Surveillance Research Program for the Assessment of the Safety and the Effectiveness of Linagliptin

Who this might be right for
Diabetes Mellitus, Type 2
Boehringer Ingelheim 189,426
Large-scale testing (Phase 3)Study completedNCT00740051
What this trial is testing

A Randomised, db, Placebo-controlled Study of BI 1356 for 18 Weeks Followed by a 34 Week Double-blind Extension Period (Placebo Patients Switched to Glimepiride) in Type 2 Diabetic Patients for Whom Treatment With Metformin is Inappropriate

Who this might be right for
Diabetes Mellitus, Type 2
Boehringer Ingelheim 227
Post-approval studies (Phase 4)Study completedNCT04088461
What this trial is testing

Effect of Linagliptin + Metformin on Patients Who do Not Achieve Normoglucemia With Metformine

Who this might be right for
Prediabetic StateImpaired Glucose ToleranceInsulin Resistance
Universidad de Guanajuato 31
Not applicableStudy completedNCT03338803
What this trial is testing

Real World Glycemic Effectiveness of Linagliptin

Who this might be right for
Diabetes Mellitus, Type 2
Boehringer Ingelheim 11,001
Early research (Phase 1)Study completedNCT01276327
What this trial is testing

Bioequivalence of a Fixed Dose Combination Tablet Linagliptin/Pioglitazone Compared With Its Mono-components

Who this might be right for
Healthy
Boehringer Ingelheim 64
Early research (Phase 1)Study completedNCT02857946
What this trial is testing

Bioequivalence Study of Linagliptin From Prevaglip 5 mg Tablets(Eva Pharma, Egypt) and Trajenta 5 mg Tablets (Boehringer Ingelheim International GmbH, Germany)

Who this might be right for
Healthy
Genuine Research Center, Egypt 24
Large-scale testing (Phase 3)Study completedNCT01792518
What this trial is testing

MARLINA - T2D : Efficacy, Safety & Modification of Albuminuria in Type 2 Diabetes Subjects With Renal Disease With LINAgliptin

Who this might be right for
Diabetes Mellitus, Type 2
Boehringer Ingelheim 360
Post-approval studies (Phase 4)UnknownNCT03433248
What this trial is testing

Renal Actions of Combined Empagliflozin and LINagliptin in Type 2 diabetES

Who this might be right for
Type2 Diabetes
M.H.H. Kramer 66
Large-scale testing (Phase 3)Study completedNCT03429543
What this trial is testing

Diabetes Study of Linagliptin and Empagliflozin in Children and Adolescents (DINAMO)TM

Who this might be right for
Diabetes Mellitus, Type 2
Boehringer Ingelheim 175
Large-scale testing (Phase 3)Study completedNCT00622284
What this trial is testing

Efficacy and Safety of BI 1356 in Combination With Metformin in Patients With Type 2 Diabetes

Who this might be right for
Diabetes Mellitus, Type 2
Boehringer Ingelheim 1,560
Post-approval studies (Phase 4)Study completedNCT02106104
What this trial is testing

Renal Effects of DPP-4 Inhibitor Linagliptin in Type 2 Diabetes

Who this might be right for
Type 2 Diabetes
Amsterdam UMC, location VUmc 48
Early research (Phase 1)Study completedNCT00935220
What this trial is testing

Pharmacokinetics and Pharmacodynamics Trial With Linagliptin (BI 1356) 5mg in African American Type 2 Diabetic Patients

Who this might be right for
Diabetes Mellitus, Type 2
Boehringer Ingelheim 41
Early research (Phase 1)Study completedNCT01703286
What this trial is testing

Trial to Assess the Influence of 4 Weeks' Treatment With Linagliptin as Compared to Glimepiride and Placebo on Endothelial Function in Patients With Type 2 Diabetes Using FMD (Flow-Mediated Vasodilation)

Who this might be right for
Diabetes Mellitus, Type 2
Boehringer Ingelheim 42
Not applicableNot Yet RecruitingNCT07786571
What this trial is testing

Study on Improving Blood Glucose Homeostasis With Dorzagliatin Tablets in the Treatment of Type 2 Diabetes Mellitus Patients With Moderate to Severe Chronic Renal Insufficiency

Who this might be right for
Type 2 Diabetes Mellitus (T2DM)Chronic Renal InsufficiencyChronic Kidney Disease (Stages 3b-5)+1 more
Sun Yat-sen University 206
Large-scale testing (Phase 3)Study completedNCT02376075
What this trial is testing

Effects of Linagliptin on Endothelial- , Renal-, and Retinal Function in Patients With Hypertension and Albuminuria

Who this might be right for
Arterial HypertensionAlbuminuria
ikfe-CRO GmbH 43
Testing effectiveness (Phase 2)Study completedNCT00309608
What this trial is testing

Efficacy and Safety of BI 1356 BS (Linagliptin) in Combination With Metformin in Patients With type2 Diabetes

Who this might be right for
Diabetes Mellitus, Type 2
Boehringer Ingelheim 333
Next Page